Medtech

Search documents
Spotlight on Johnson & Johnson: Analyzing the Surge in Options Activity - Johnson & Johnson (NYSE:JNJ)
Benzinga· 2025-09-25 19:01
Financial giants have made a conspicuous bullish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson (NYSE: JNJ) revealed 17 unusual trades.Delving into the details, we found 58% of traders were bullish, while 23% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $283,763, and 14 were calls, valued at $935,177.Projected Price TargetsAnalyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a ...
Cramer's Mad Dash: Johnson & Johnson
CNBC Television· 2025-07-16 14:51
Let's get a Wednesday edition of Kramer's Mad Dash. The best non-bank is J&J. I mean, this J&J quarter, it may set, you know, they're not talking that much about tariffs.Uh, that is going to happen. They're probably a later thing. But I was stunned.The oncology sales are incredible, up 24%. They have new bladder cancer. Uh, I nothing's a cure, but great maintenance that I think uh medtech finally came back.It was really sensational. Uh, a lot of people were thinking that medtech was weaker. uh neuroscience ...